Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;18(2):680-3.
doi: 10.1158/1055-9965.EPI-08-0961. Epub 2009 Feb 3.

A two-stage case-control study of EGFR polymorphisms and breast cancer risk

Young-Seoub Hong  1 , Sandra L Deming, Yu-Tang Gao, Ji-Rong Long, Xiao-Ou Shu, Qiuyin Cai, Wei Lu, Wei Zheng
Affiliations

A two-stage case-control study of EGFR polymorphisms and breast cancer risk

Young-Seoub Hong et al. Cancer Epidemiol Biomarkers Prev. 2009 Feb.
No abstract available

PubMed Disclaimer

References

    1. O'Driscoll L, Clynes M. Biomarkers and multiple drug resistance in breast cancer. Curr Cancer Drug Targets. 2006;6:365–384. - PubMed
    1. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomark Prev. 1999;8:843–854. - PubMed
    1. Bianco R, Gelardi T, Damiano V, Ciardello F, Tortora G. Rational bases for the development of EGFR inhibitors for cancer treatment. Int J Biochem Cell Biol. 2007;39:1416–1431. - PubMed
    1. Merlinov G, Ishii N, Whang PJ, et al. Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol. 1985;5:1722–1734. - PMC - PubMed
    1. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer. 2000;87:295–300. - PubMed

Publication types